tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Prestige Consumer Healthcare Acquires Pillar5 Pharma for Expansion

Story Highlights
Prestige Consumer Healthcare Acquires Pillar5 Pharma for Expansion

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Prestige Consumer Healthcare ( (PBH) ) has provided an update.

On August 4, 2025, Prestige Consumer Healthcare Inc. announced a definitive agreement to acquire Pillar5 Pharma Inc., a leading Canadian sterile ophthalmic manufacturer and current supplier of Clear Eyes, from ANJAC SAS for CAD 150 million. This acquisition is part of Prestige’s strategy to expand eye care production capacity and address supply chain challenges, with the transaction expected to close in the third quarter of fiscal 2026. The company also reported a decline in first-quarter fiscal 2026 revenue to $249.5 million due to supply constraints in the eye care category, although international segment growth and improved gross margins were noted. The acquisition of Pillar5 is anticipated to secure long-term supply chain capacity and support Prestige’s growth opportunities, despite a revised revenue outlook for fiscal 2026.

The most recent analyst rating on (PBH) stock is a Hold with a $90.00 price target. To see the full list of analyst forecasts on Prestige Consumer Healthcare stock, see the PBH Stock Forecast page.

Spark’s Take on PBH Stock

According to Spark, TipRanks’ AI Analyst, PBH is a Neutral.

The overall stock score reflects strong financial performance and positive earnings guidance. However, technical analysis indicates bearish momentum, and moderate valuation limits the upside potential. The lack of a dividend yield might deter some investors.

To see Spark’s full report on PBH stock, click here.

More about Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc. operates in the healthcare industry, focusing on over-the-counter (OTC) healthcare products. The company is known for its diverse portfolio of needs-based products, including eye care solutions, with a significant market focus on international and North American segments.

Average Trading Volume: 387,368

Technical Sentiment Signal: Buy

Current Market Cap: $3.65B

Find detailed analytics on PBH stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1